Bank of New York Mellon’s Strata Critical Medical, Inc. Class A Common Stock SRTA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $591K | Buy |
146,696
+8,135
| +6% | +$32.8K | ﹤0.01% | 3395 |
|
2025
Q1 | $378K | Hold |
138,561
| – | – | ﹤0.01% | 3571 |
|
2024
Q4 | $589K | Buy |
138,561
+4,118
| +3% | +$17.5K | ﹤0.01% | 3416 |
|
2024
Q3 | $395K | Sell |
134,443
-53,497
| -28% | -$157K | ﹤0.01% | 3622 |
|
2024
Q2 | $654K | Buy |
187,940
+26,326
| +16% | +$91.6K | ﹤0.01% | 3421 |
|
2024
Q1 | $461K | Sell |
161,614
-11,883
| -7% | -$33.9K | ﹤0.01% | 3564 |
|
2023
Q4 | $612K | Buy |
173,497
+778
| +0.5% | +$2.75K | ﹤0.01% | 3436 |
|
2023
Q3 | $447K | Hold |
172,719
| – | – | ﹤0.01% | 3603 |
|
2023
Q2 | $681K | Buy |
172,719
+1,859
| +1% | +$7.32K | ﹤0.01% | 3426 |
|
2023
Q1 | $578K | Sell |
170,860
-2,639
| -2% | -$8.92K | ﹤0.01% | 3417 |
|
2022
Q4 | $621K | Buy |
173,499
+4,349
| +3% | +$15.6K | ﹤0.01% | 3440 |
|
2022
Q3 | $682K | Buy |
169,150
+15,617
| +10% | +$63K | ﹤0.01% | 3393 |
|
2022
Q2 | $685K | Buy |
153,533
+136,139
| +783% | +$607K | ﹤0.01% | 3405 |
|
2022
Q1 | $148K | Hold |
17,394
| – | – | ﹤0.01% | 4326 |
|
2021
Q4 | $154K | Hold |
17,394
| – | – | ﹤0.01% | 4339 |
|
2021
Q3 | $181K | Buy |
17,394
+174
| +1% | +$1.81K | ﹤0.01% | 4234 |
|
2021
Q2 | $181K | Buy |
+17,220
| New | +$181K | ﹤0.01% | 4114 |
|